Cell Signaling Technology

ADH1 Antibody

#5295 · $314

100
Citing papers
8.7k
Combined citations
Supplier page Find this product

Research areas

Signaling Pathways in Disease11NF-κB Signaling Pathways9MicroRNA in disease regulation9Autophagy in Disease and Therapy8Peptidase Inhibition and Analysis7Cancer Mechanisms and Therapy6Cell death mechanisms and regulation5Chromatin Remodeling and Cancer5

Papers citing this product

1
Snail blocks the cell cycle and confers resistance to cell death
Genes & Development·2004·871 cit.·DOI
2
Modulation of Pro-survival Akt/Protein Kinase B and ERK1/2 Signaling Cascades by Quercetin and Its in Vivo Metabolites Underlie Their Action on Neuronal Viability
Journal of Biological Chemistry·2003·350 cit.·DOI
3
Exosome-mediated breast cancer chemoresistance via miR-155 transfer
Scientific Reports·2018·332 cit.·DOI
4
EBV and human microRNAs co‐target oncogenic and apoptotic viral and human genes during latency
The EMBO Journal·2012·289 cit.·DOI
5
Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix
British Journal of Cancer·2019·285 cit.·DOI
6
Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF
Nucleic Acids Research·2009·194 cit.·DOI
7
Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages
Nature Communications·2021·183 cit.·DOI
8
A palmitoylation switch mechanism regulates Rac1 function and membrane organization
The EMBO Journal·2011·179 cit.·DOI
9
Oleate Promotes the Proliferation of Breast Cancer Cells via the G Protein-coupled Receptor GPR40
Journal of Biological Chemistry·2005·177 cit.·DOI
10
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance
Nature Communications·2019·171 cit.·DOI
ADH1 Antibody — Evidence — PubIndex